REBECCA SALLY: Open Payments
NPI 1730463530 · MC MURRAY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,171 in 190 payments from 20 companies in 2025. Trend: 2023 $2,329 · 2024 $4,279 · 2025 $3,171
Food & beverage: $3,161Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $515 |
| GENZYME CORPORATION | 12 | $292 |
| ABBVIE INC. | 35 | $280 |
| UCB, Inc. | 16 | $258 |
| Galderma Laboratories, L.P. | 19 | $219 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $198 |
| Incyte Corporation | 8 | $183 |
| Regeneron Healthcare Solutions, Inc. | 6 | $179 |
| MAYNE PHARMA COMMERCIAL LLC | 10 | $173 |
| Organon LLC | 12 | $159 |
Products named: DUPIXENT, TREMFYA, Bimzelx, SKYRIZI, OPZELURA, NEMLUVIO, OTEZLA, AXERT.
Industry payments across PA — which companies pay providers there.
